arrow
L

Lionel Rougé

Genentech
H指数:25
被引数:3,055

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lysosomal polyamine storage upon ATP13A2 loss impairs β-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions

ATP13A2缺失导致的溶酶体多胺储存通过改变溶酶体pH值和静电水解酶-脂质相互作用而损害β-葡糖脑苷脂酶

2025-08-220
PREAI
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
2022-04-0110
OAAI
Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy
2021-03-2229
PRE
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
2021-02-2374
OAAI
A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel
NEURON
IF15
2021-01-0157
OAAI
Development and mechanistic characterization of USP7 deubiquitinase inhibitors
2018-07-010
PRE
Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series

利用pre-dfg残基Thr-406在氨基吡唑型PAK1抑制剂系列中获得高激酶选择性

2015-05-2215
OAAI
Back Pocket Flexibility Provides Group II p21-Activated Kinase (PAK) Selectivity for Type I 1/2 Kinase Inhibitors
2014-02-0465
PREAI
Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer

发现一种用于治疗癌症的有效,选择性和口服可用的I类磷脂酰肌醇3激酶 (PI3K)/哺乳动物雷帕霉素靶蛋白 (mTOR) 激酶抑制剂 (GDC-0980)

2011-10-07207
PREAI